Cyclophosphamide Equivalent Dose

Daniel M. Green, Vikki G. Nolan, Pamela J. Goodman, John A. Whitton, DeoKumar Srivastava, Wendy M. Leisenring, Joseph P. Neglia, Charles A. Sklar, Sue C. Kaste, Melissa M. Hudson, Lisa R. Diller, Marilyn Stovall, Sarah S. Donaldson, Leslie L. Robison, The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study Pediatric Blood & Cancer. ,vol. 61, pp. 53- 67 ,(2014) , 10.1002/PBC.24679

Marie-Cécile Le Deley, Michael Paulussen, Ian Lewis, Bernadette Brennan, Andreas Ranft, Jeremy Whelan, Gwénaël Le Teuff, Jean Michon, Ruth Ladenstein, Perrine Marec-Bérard, Henk van den Berg, Lars Hjorth, Keith Wheatley, Ian Judson, Heribert Juergens, Alan Craft, Odile Oberlin, Uta Dirksen, Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial Journal of Clinical Oncology. ,vol. 32, pp. 2440- 2448 ,(2014) , 10.1200/JCO.2013.54.4833

Lesley A Smith, Victoria R Cornelius, Christopher J Plummer, Gill Levitt, Mark Verrill, Peter Canney, Alison Jones, Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials BMC Cancer. ,vol. 10, pp. 337- 337 ,(2010) , 10.1186/1471-2407-10-337